Journal
/
/
Etablering og karakterisering av tre Afatinib-resistente Lung Adenokarsinom PC-9 Cell Lines utviklet med økende doser av Afatinib
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
DOI:

09:38 min

June 26, 2019

, , , ,

Chapters

  • 00:04Title
  • 00:38Initial Afatinib PC-9 Cell Exposure Determination by 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) Assay
  • 01:46Continuous Afatinib Exposure
  • 03:01PC-9 Cell Growth Curve Determination
  • 03:46Epidermal Growth Factor Receptor (EGFR) Genomic DNA Alteration Evaluation
  • 04:53Epidermal Growth Factor Receptor (EGFR) Protein Alteration Evaluation
  • 07:39Results: Afatinib-resistant Cell Characterization
  • 08:59Conclusion

Summary

Automatic Translation

En metode for å etablere afatinib-motstand cellelinjer fra lunge adenokarsinom PC-9-celler ble utviklet, og resistente celler ble karakterisert. De resistente cellene kan brukes til å undersøke epidermal vekstfaktorreseptor tyrosin kinase hemmer-motstand mekanismer, gjelder for pasienter med ikke-liten celle lungekreft.

Related Videos

Read Article